Analysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework. Issue 9 (3rd May 2018)
- Record Type:
- Journal Article
- Title:
- Analysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework. Issue 9 (3rd May 2018)
- Main Title:
- Analysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework
- Authors:
- Moody, Marykathryn Tynon
Diaz, Stephanie
Shah, Parul
Papsun, Donna
Logan, Barry K. - Abstract:
- Abstract: In recent years an increasing number of novel opioids have appeared on the illicit drug market and have been linked to the growing opioid crisis in the United States. It is suspected that synthetic‐opioid‐related deaths are underestimated since many laboratories either use a screening method that is not specific and sensitive enough for these compounds or testing is not performed for fentanyl and its related analogs in general. We describe a method for the analysis of 19 of the most current novel opioid drugs quantitatively in whole blood and serum, and 17 analytes qualitatively in urine using solid phase extraction with liquid chromatography–tandem mass spectrometry (LC–MS/MS). The limit of detection was determined to be at a minimum 0.25 ng/mL for beta‐hydroxythiofentanyl, 0.05 ng/mL for butyryl/isobutyrylfentanyl, AH‐7921, 2‐furanylfentanyl, 4‐ANPP, and U‐47700; 0.025 ng/mL for MT‐45, para‐methoxybutyrylfentanyl, 4‐methylphenethyl acetyl fentanyl, U‐50488, acrylfentanyl, valerylfentanyl, and carfentanil; and 0.0125 ng/mL for para‐fluorofentanyl, ortho‐fluorofentanyl, para‐fluorobutyrylfentanyl/FIBF, and alpha‐methylfentanyl. The lower limit of quantitation was determined to be 0.1 ng/mL for all analytes except AH‐7921, U‐47700, U‐50488 which were 0.05 ng/mL and beta‐hydroxythiofentanyl which was 0.5 ng/mL. The method was validated successfully according to a Scientific Working Group in Forensic Toxicology (SWGTOX) compliant approach. This method was applied toAbstract: In recent years an increasing number of novel opioids have appeared on the illicit drug market and have been linked to the growing opioid crisis in the United States. It is suspected that synthetic‐opioid‐related deaths are underestimated since many laboratories either use a screening method that is not specific and sensitive enough for these compounds or testing is not performed for fentanyl and its related analogs in general. We describe a method for the analysis of 19 of the most current novel opioid drugs quantitatively in whole blood and serum, and 17 analytes qualitatively in urine using solid phase extraction with liquid chromatography–tandem mass spectrometry (LC–MS/MS). The limit of detection was determined to be at a minimum 0.25 ng/mL for beta‐hydroxythiofentanyl, 0.05 ng/mL for butyryl/isobutyrylfentanyl, AH‐7921, 2‐furanylfentanyl, 4‐ANPP, and U‐47700; 0.025 ng/mL for MT‐45, para‐methoxybutyrylfentanyl, 4‐methylphenethyl acetyl fentanyl, U‐50488, acrylfentanyl, valerylfentanyl, and carfentanil; and 0.0125 ng/mL for para‐fluorofentanyl, ortho‐fluorofentanyl, para‐fluorobutyrylfentanyl/FIBF, and alpha‐methylfentanyl. The lower limit of quantitation was determined to be 0.1 ng/mL for all analytes except AH‐7921, U‐47700, U‐50488 which were 0.05 ng/mL and beta‐hydroxythiofentanyl which was 0.5 ng/mL. The method was validated successfully according to a Scientific Working Group in Forensic Toxicology (SWGTOX) compliant approach. This method was applied to the analysis of 2758 samples between October 2016 and September 2017. It was determined that 4‐ANPP, furanylfentanyl, and carfentanil were the 3 most prevalent fentanyl related compounds detected: 56.1% of cases were positive for 4‐ANPP, 44.5% were positive for furanylfentanyl, and 25.2% cases were positive for carfentanil. Abstract : In recent years increasing number of novel opioids have appeared of the illicit drug market and have been linked to the growing opioid crisis in the United States. We describe a method for the analysis of 19 of the most current novel opioid drugs quantitatively in whole blood and serum, and 17 analytes quantitatively in urine using solid phase extraction with liquid chromatography tandem mass spectrometry (LCMS/MS). … (more)
- Is Part Of:
- Drug testing and analysis. Volume 10:Issue 9(2018)
- Journal:
- Drug testing and analysis
- Issue:
- Volume 10:Issue 9(2018)
- Issue Display:
- Volume 10, Issue 9 (2018)
- Year:
- 2018
- Volume:
- 10
- Issue:
- 9
- Issue Sort Value:
- 2018-0010-0009-0000
- Page Start:
- 1358
- Page End:
- 1367
- Publication Date:
- 2018-05-03
- Subjects:
- Designer opioids -- forensic toxicology -- liquid chromatography–mass spectrometry
Drugs -- Analysis -- Periodicals
Drug testing -- Periodicals
Chemistry, Forensic -- Periodicals
615.1901 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=110501 ↗
http://www3.interscience.wiley.com/journal/121408477/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/dta.2393 ↗
- Languages:
- English
- ISSNs:
- 1942-7603
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.424000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7676.xml